CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CMG Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CMG Pharmaceutical Co Ltd
14, Dosan-daero 66-gil, Gangnam-gu
Phone: +82 318817600p:+82 318817600 SEOUL, 06112  South Korea Ticker: 058820058820
Business Summary
CMG Pharmaceutical Co., Ltd is a Korea-based company specialized in the manufacture of pharmaceuticals. The Company’s products include antibiotics, antifungals, antivirus, anti-tuberculousis drugs, peptic ulcer drugs, dementia remedies, antihistamines and antipyretics, among others. It is also engaged in the manufacture of stone products. The Company mainly distributes is pharmaceutical products within domestic markets, as well as to overseas markets. On April 16, 2013, the Company changed its name from SKYNEWPHARM. Co., Ltd to CMG Pharmaceutical Co., Ltd.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
3281 Cut stone and stone products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jeong HoKim 64 3/31/2014 3/31/2014
Vice President, Director Gyeong WukYoon 46 11/8/2012 11/8/2012
Internal Auditor Yin SuPark 70 11/8/2012 11/8/2012
3 additional Officers and Directors records available in full report.

Business Names
Business Name
058820
cellart pharm. korea co., ltd.
P.M.K. Co., Ltd.
Skynewpharm Co., Ltd.

General Information
Number of Employees: 248 (As of 12/31/2022)
Outstanding Shares: 138,892,244 (As of 12/31/2023)
Shareholders: 40,301
Stock Exchange: KDQ
Fax Number: +82 318817670


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024